Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Response to IJTLD article, "Having diabetes and being underweight in Asia: a potent risk factor for tuberculosis".
van Crevel R, Andia-Biraro I, Ntinginya NE, Chamba N, Critchley J, Te Brake L, Kibirige D, Manyama CK, Kilonzo K, Pennington M, Sharples K, Hill PC. van Crevel R, et al. Among authors: ntinginya ne. Int J Tuberc Lung Dis. 2020 Jun 1;24(6):632-633. doi: 10.5588/ijtld.20.0033. Int J Tuberc Lung Dis. 2020. PMID: 32552998 No abstract available.
A continuously monitored colorimetric method for detection of Mycobacterium tuberculosis complex in sputum.
Rojas-Ponce G, Rachow A, Guerra H, Mapamba D, Joseph J, Mlundi R, Marimoto S, Ntinginya NE, Mangu C, Framhein A, Butler A, Kohlenberg A, Ngatemelela D, Froeschl G, Maboko L, Hoelscher M, Heinrich N. Rojas-Ponce G, et al. Among authors: ntinginya ne. Int J Tuberc Lung Dis. 2013 Dec;17(12):1607-12. doi: 10.5588/ijtld.13.0317. Int J Tuberc Lung Dis. 2013. PMID: 24200277
Optimising molecular diagnostic capacity for effective control of tuberculosis in high-burden settings.
Sabiiti W, Mtafya B, Kuchaka D, Azam K, Viegas S, Mdolo A, Farmer EC, Khonga M, Evangelopoulos D, Honeyborne I, Rachow A, Heinrich N, Ntinginya NE, Bhatt N, Davies GR, Jani IV, McHugh TD, Kibiki G, Hoelscher M, Gillespie SH; PANBIOME (Pan-African Biomarker Expansion Programme) consortium. Sabiiti W, et al. Among authors: ntinginya ne. Int J Tuberc Lung Dis. 2016 Aug;20(8):1004-9. doi: 10.5588/ijtld.15.0951. Int J Tuberc Lung Dis. 2016. PMID: 27393531
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.
Boeree MJ, Heinrich N, Aarnoutse R, Diacon AH, Dawson R, Rehal S, Kibiki GS, Churchyard G, Sanne I, Ntinginya NE, Minja LT, Hunt RD, Charalambous S, Hanekom M, Semvua HH, Mpagama SG, Manyama C, Mtafya B, Reither K, Wallis RS, Venter A, Narunsky K, Mekota A, Henne S, Colbers A, van Balen GP, Gillespie SH, Phillips PPJ, Hoelscher M; PanACEA consortium. Boeree MJ, et al. Among authors: ntinginya ne. Lancet Infect Dis. 2017 Jan;17(1):39-49. doi: 10.1016/S1473-3099(16)30274-2. Epub 2016 Oct 26. Lancet Infect Dis. 2017. PMID: 28100438 Free PMC article. Clinical Trial.
Clinical-demographic markers for improving diabetes mellitus diagnosis in people with tuberculosis in Tanzania.
Byashalira KC, Chamba NG, Alkabab Y, Mbelele PM, Ntinginya NE, Ramaiya KL, Alimohamed MZ, Heysell SK, Mmbaga BT, Bygbjerg IC, Christensen DL, Mpagama SG, Lillebaek T; ADEPT Consortium. Byashalira KC, et al. Among authors: ntinginya ne. BMC Infect Dis. 2022 Mar 16;22(1):260. doi: 10.1186/s12879-022-07249-x. BMC Infect Dis. 2022. PMID: 35296241 Free PMC article.
Rifapentine and isoniazid for prevention of tuberculosis in people with diabetes (PROTID): protocol for a randomised controlled trial.
Ntinginya NE, Te Brake L, Sabi I, Chamba N, Kilonzo K, Laizer S, Andia-Biraro I, Kibirige D, Kyazze AP, Ninsiima S, Critchley JA, Romeo R, van de Maat J, Olomi W, Mrema L, Magombola D, Mwayula IH, Sharples K, Hill PC, van Crevel R; PROTID Consortium. Ntinginya NE, et al. Trials. 2022 Jun 10;23(1):480. doi: 10.1186/s13063-022-06296-8. Trials. 2022. PMID: 35689272 Free PMC article.
Impact of early diagnosis of impaired glucose regulation in tuberculosis: Comparison of clinical outcomes in people with tuberculosis in Tanzania.
Byashalira KC, Chamba NG, Alkabab Y, Mbelele PM, Mpolya EA, Ntinginya NE, Shayo PJ, Ramaiya KL, Lillebaek T, Heysell SK, Mmbaga BT, Bygbjerg IC, Mpagama SG, Christensen DL; ADEPT consortium. Byashalira KC, et al. Among authors: ntinginya ne. Trop Med Int Health. 2022 Sep;27(9):815-822. doi: 10.1111/tmi.13806. Epub 2022 Aug 28. Trop Med Int Health. 2022. PMID: 36053910 Free article.
Where can Tanzania health system integrate clinical management of patients with dual tuberculosis and diabetes mellitus? A cross-sectional survey at varying levels of health facilities.
Chamba NG, Byashalira KC, Shayo PJ, Ramaiya KL, Manongi RN, Daud P, Mmbaga BT, Ntinginya NE, Lillebæk T, Bygbjerg IC, Christensen DL, Mpagama SG. Chamba NG, et al. Among authors: ntinginya ne. Public Health Pract (Oxf). 2022 Mar 3;3:100242. doi: 10.1016/j.puhip.2022.100242. eCollection 2022 Jun. Public Health Pract (Oxf). 2022. PMID: 36101768 Free PMC article.
Indicators of optimal diabetes care and burden of diabetes complications in Africa: a systematic review and meta-analysis.
Kibirige D, Chamba N, Andia-Biraro I, Kilonzo K, Laizer SN, Sekitoleko I, Kyazze AP, Ninsiima S, Ssekamatte P, Bongomin F, Mrema LE, Olomi W, Mbunda TD, Ntinginya NE, Sabi I, Sharples K, Hill P, Te Brake L, VandeMaat J, vanCrevel R, Critchley JA; PROTID consortium. Kibirige D, et al. Among authors: ntinginya ne. BMJ Open. 2022 Nov 8;12(11):e060786. doi: 10.1136/bmjopen-2022-060786. BMJ Open. 2022. PMID: 36351737 Free PMC article.
106 results